Evidence map›Paper›PMID 37675782›Full record

ArticleThe journal of histochemistry and cytochemistry : official journal of the Histochemistry Society2023

Paradoxical Expression of R-10G-reactive Antigen in Human Testicular Embryonal Carcinoma.

Akifumi Muramoto, So Inamura, Hitomi Hoshino, Naoki Terada, Motohiro Kobayashi

Open access · greenAbstract read
In one paragraph

Article in The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Expression of Podocalyxin Potentially Decorated With Low-sulfated Keratan Sulfate in Human Testicular Embryonal Carcinoma.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Akifumi MuramotoDepartment of Tumor Pathology, Faculty of Medical Sciences, University of Fukui, Eiheiji, Japan.ORCID 0000-0002-1261-5059
So InamuraDepartment of Tumor Pathology.
Hitomi HoshinoDepartment of Tumor Pathology, Faculty of Medical Sciences, University of Fukui, Eiheiji, Japan.
Naoki TeradaDepartment of Urology, Faculty of Medical Sciences, University of Fukui, Eiheiji, Japan.ORCID 0000-0002-3591-1715
Motohiro KobayashiDepartment of Tumor Pathology, Faculty of Medical Sciences, University of Fukui, Eiheiji, Japan.ORCID 0000-0002-7607-0801
University of Fukui · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thus far, several monoclonal antibodies directed against cell-surface carbohydrate antigens have been generated. Among them, R-10G reportedly reacts selectively with human embryonic stem and induced pluripotent stem cells, but not with embryonal carcinoma (EC) cells. However, EC cells derived from patients' EC tumors may exhibit varying levels of R-10G-reactive antigen expression. Thus, we asked whether human EC tissues or germ cell tumor (GCT) tissues other than EC express R-10G-reactive antigen. To do so, we quantitatively analyzed R-10G-reactive antigen expression in 83 testicular GCT surgical specimens containing a total of 125 various GCT components. Accordingly, in all EC components examined, the EC cell plasma membrane was immunolabeled with R-10G, while most seminoma components were R-10G-negative. In non-seminomatous GCT (NSGCT) other than EC (non-EC NSGCT), R-10G-reactive antigen expression was variable, but signal distribution was focal, and the average intensity was weaker than that seen in EC. The percentages of R-10G-positive cells in these three groups varied with high statistical significance (

Indexed as

Carcinoma, EmbryonalNeoplasms, Germ Cell and EmbryonalTesticular NeoplasmsAntibodies, MonoclonalBiomarkers, TumorHumansMaleAntibodies, MonoclonalBiomarkers, Tumorimmunohistochemistrykeratan sulfatetestis

Identifiers

PMID37675782
PMCPMC10546982
OpenAlexW4386503902

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.